Switch to Patients and Caregivers
Email Page
Print Page
Rituxan Access Solutions—Committed to Helping Your Patients Access Rituxan (rituximab)
At Genentech, we develop medicines for serious or life-threatening medical conditions and we believe they should be accessible to the patients who need them. Rituxan Access Solutions helps resolve specific access and reimbursement issues for individual patients every day.
Coverage and Reimbursement
For you and your patients, Rituxan Access Solutions provides coverage and reimbursement support, patient assistance and informational resources. Our specialists are passionate about helping patients access Rituxan and exploring every appropriate solution to coverage or reimbursement issues.
Patient Assistance
To learn more about our patient assistance programs, please click on the button that applies to your patient.
- Your patient is uninsured or rendered uninsured by payer denial
- Your patient has health insurance and needs help with co-pay*
Informational Resources
We know it’s important to have the right information at your fingertips. With this in mind, we’ve compiled a list of informational resources you may find useful.
Rituxan (Rituximab) INDICATIONS AND USAGE
Non-Hodgkin's Lymphoma (NHL)
Rituxan® is indicated for the treatment of patients with:
- Relapsed or refractory, low-grade or follicular, CD20-positive, B-cell NHL as a single agent
- Previously untreated follicular, CD20-positive, B-cell NHL in combination with CVP chemotherapy
- Non-progressing (including stable disease), low-grade, CD20-positive B-cell NHL, as a single agent, after first-line CVP chemotherapy
- Previously untreated diffuse large B-cell, CD20-positive NHL in combination with CHOP or other anthracycline-based chemotherapy regimens
Rituxan Boxed WARNINGS and Additional Important Safety Information
The most important serious adverse reactions of Rituxan are fatal infusion reactions, tumor lysis syndrome (TLS), severe mucocutaneous reactions, progressive multifocal leukoencephalopathy (PML), hepatitis B reactivation with fulminant hepatitis, other viral infections, cardiovascular events, renal toxicity, and bowel obstruction and perforation. The most common adverse reactions of Rituxan (incidence ≥25%) observed in patients with NHL are infusion reactions, fever, chills, infection, asthenia, and lymphopenia. The most common adverse reactions of Rituxan observed in patients with RA are hypertension, nausea, upper respiratory tract infection, arthralgia, pruritus, and pyrexia.
Attention healthcare provider: Provide Medication Guide to patient prior to Rituxan infusion.
For additional safety information, please see the full prescribing information, including Boxed WARNINGS and Medication Guide.
*Co-pay refers to a cost-sharing arrangement in which members of health insurance plans pay a specified charge for a product or service, such as a prescription or an office visit. Members are typically responsible for this payment at the time of service.
Privacy information: This site is being offered to you, the health care provider, on behalf of your patients, with the understanding that if you intend to request the assistance of Rituxan Access Solutions with respect to access to or reimbursement for a Genentech medicine for a specific patient, you must obtain a signed Patient Authorization and Notice of Release of Information (PAN) form (description/PDF) from your patient to provide his or her information to Rituxan Access Solutions. Any information submitted to Rituxan Access Solutions will remain confidential and will not be used for promotional purposes.
If you would like to learn more about protecting the privacy of personal health information, please go to the U.S. Department of Health & Human Services website at www.hhs.gov/ocr/hipaa/.
Rituxan Access Solutions provides forms and documents in Adobe® Portable Document Format (PDF). In order to view PDF files, you must have Adobe® Reader® installed on your computer. If you don't have Adobe Reader or have an earlier version of Adobe Acrobat, you can download the most recent version for free at the Adobe Reader download site.
To open a PDF, simply click on the link. This will open the PDF in a new window. All PDFs can be printed or saved to your computer using the tools at the top of the PDF window. The "type-in" PDFs allow you to type directly into the form fields (instead of printing and filling out by hand).
